SCI Pharmtech Inc (4119) — Financial Flexibility Index
SCI Pharmtech Inc (4119) has a Financial Flexibility Index of 0.13x as of June 2026. Free cash flow of NT$217.75 Million (operating CF NT$156.75 Million minus capex NT$60.99 Million) represents 0% of total liabilities (NT$1.62 Billion). Check total reinvestment intensity of SCI Pharmtech Inc to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
SCI Pharmtech Inc Financial Flexibility Index (2002–2025)
Historical Financial Flexibility Index trend for SCI Pharmtech Inc across 23 annual periods. For the full cash flow conversion analysis, see 4119 cash generation efficiency.
Annual Financial Flexibility Index for SCI Pharmtech Inc (2002–2025)
Year-by-year free cash flow to debt coverage for SCI Pharmtech Inc. Explore cash flow to debt ratio of SCI Pharmtech Inc to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (TWD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.56x | NT$830.32 Million | NT$220.32 Million | NT$1.49 Billion | ▼ -46.9% |
| 2024 | 1.05x | NT$1.81 Billion | NT$860.52 Million | NT$1.72 Billion | ▲ +33.9% |
| 2023 | 0.78x | NT$1.25 Billion | NT$215.77 Million | NT$1.59 Billion | ▼ -28.8% |
| 2022 | 1.10x | NT$1.46 Billion | NT$296.56 Million | NT$1.33 Billion | ▼ -9.4% |
| 2021 | 1.21x | NT$1.06 Billion | NT$280.28 Million | NT$869.26 Million | ▲ +27.4% |
| 2020 | 0.95x | NT$1.19 Billion | NT$971.53 Million | NT$1.25 Billion | ▼ -41.9% |
| 2019 | 1.64x | NT$996.08 Million | NT$791.60 Million | NT$606.84 Million | ▲ +47.9% |
| 2018 | 1.11x | NT$642.63 Million | NT$480.18 Million | NT$578.85 Million | ▼ -5.3% |
| 2017 | 1.17x | NT$429.04 Million | NT$281.65 Million | NT$365.88 Million | ▼ -17.2% |
| 2016 | 1.42x | NT$679.31 Million | NT$502.11 Million | NT$479.43 Million | ▲ +11.8% |
| 2015 | 1.27x | NT$880.75 Million | NT$663.24 Million | NT$695.02 Million | ▲ +73.2% |
| 2014 | 0.73x | NT$727.92 Million | NT$358.77 Million | NT$994.64 Million | ▼ -28.8% |
| 2013 | 1.03x | NT$1.01 Billion | NT$238.57 Million | NT$984.62 Million | ▼ -41.8% |
| 2012 | 1.76x | NT$566.47 Million | NT$385.57 Million | NT$321.12 Million | ▲ +71.1% |
| 2011 | 1.03x | NT$397.26 Million | NT$249.55 Million | NT$385.26 Million | ▼ -5.9% |
| 2010 | 1.10x | NT$409.30 Million | NT$218.96 Million | NT$373.37 Million | ▼ -52.8% |
| 2009 | 2.32x | NT$498.09 Million | NT$316.96 Million | NT$214.32 Million | ▲ +15.3% |
| 2008 | 2.02x | NT$383.42 Million | NT$245.29 Million | NT$190.16 Million | ▲ +6.5% |
| 2007 | 1.89x | NT$334.74 Million | NT$167.53 Million | NT$176.74 Million | ▼ -38.8% |
| 2006 | 3.09x | NT$293.62 Million | NT$131.62 Million | NT$94.94 Million | ▲ +255.8% |
| 2004 | 0.87x | NT$112.16 Million | NT$76.61 Million | NT$129.03 Million | ▼ -70.9% |
| 2003 | 2.98x | NT$307.15 Million | NT$206.86 Million | NT$102.99 Million | ▲ +416.4% |
| 2002 | 0.58x | NT$148.85 Million | NT$107.12 Million | NT$257.76 Million | — |